Polyrizon Ltd - התחייבויות לטווח ארוך של החברה PLRZ

Polyrizon Ltd production facilities are currently engaged in clinical trials, while cleanrooms are being upgraded to meet global standards. Management is focused on expanding patents and achieving global certification for its antiviral sprays. Historical price action, where the indicator stands at 0.00, underscores the company's market strength driven by its unique physical nasal barrier technology, for which demand surges during epidemic periods.

Polyrizon Ltd (PLRZ) is effectively scaling the distribution of nasal barriers through pharmacy chains, which requires expenditures on sterile logistics. This metric accumulates all obligations with a maturity of more than one year, measuring long-term financial stability. Investors view this balance as either a tool for expansion or a default risk. The long-term debt dynamics of Polyrizon Ltd reflect a borrowing strategy aimed at infrastructure development. Analyzing this long-term debt allows for the determination of the business's margin of safety.